Lofecam 8 Tablet contains Lornoxicam 8 mg, a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, indicated for the management of pain and inflammation associated with various musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Lornoxicam exerts its therapeutic effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to a reduction in the synthesis of prostaglandins, which are mediators of inflammation, pain, and fever. This results in effective analgesic, anti-inflammatory, and antipyretic actions. Lofecam 8 is typically prescribed for short-term use to alleviate moderate to severe pain and inflammation, improving patient mobility and quality of life. The tablet should be administered orally with or without food, as directed by a healthcare professional, with the dosage tailored to the individual’s clinical condition and response. Caution is advised in patients with a history of gastrointestinal ulcers, bleeding disorders, renal or hepatic impairment, and cardiovascular disease. Concomitant use with other NSAIDs, anticoagulants, or corticosteroids should be avoided or closely monitored due to increased risk of adverse effects. Common side effects may include gastrointestinal discomfort, dizziness, and headache. Patients should report any signs of hypersensitivity or severe adverse reactions promptly.